GT
INSP icon

Glenmede Trust’s Inspire Medical Systems INSP Stock Holding History

Glenmede Trust’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.2M Sell
81,495
-491
-0.6% -$34.4K 0.02% 469
2025
Q4 		$7.56M Buy
+81,986
New +$7.84M 0.04% 393

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Glenmede Trust's INSP Position: Q1 2026 in Review

Glenmede Trust reduced its Inspire Medical Systems (INSP) stake by 0.6% in Q1 2026, selling an estimated $34.4K and leaving 81,495 shares worth $4.2M. The position accounts for 0.02% of the portfolio, ranked #469.

Glenmede Trust first reported a position in INSP in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.56M in Q4 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Glenmede Trust held 81,495 shares of Inspire Medical Systems worth $4.2M as of Q1 2026.
  • Glenmede Trust sold 491 Inspire Medical Systems shares in Q1 2026, an estimated $34.4K.
  • Inspire Medical Systems made up 0.02% of Glenmede Trust's portfolio in Q1 2026, its #469 holding.
  • Glenmede Trust first reported a position in Inspire Medical Systems in Q4 2025 and has held it in 2 quarters since.
  • Glenmede Trust's Inspire Medical Systems position peaked at $7.56M in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.